Li-fang N. Yu

3663 North Zhongshan Road
Zhongshan, 200062, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition.

Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition.

Journal: Journal of medicinal chemistry

Published: March 06, 2025

Corrigendum to "Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis" [Europ. J. Med. Chem. 283 (2025) 117148].

Corrigendum to "Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis" [Europ. J. Med. Chem. 283 (2025) 117148].

Journal: European journal of medicinal chemistry

Published: January 08, 2025

Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis.

Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis.

Journal: European journal of medicinal chemistry

Published: October 30, 2024

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents.

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents.

Journal: European journal of medicinal chemistry

Published: March 05, 2023

Synthesis and Biological Evaluation of 3-Amino-4,4-Dimethyl Lithocholic Acid Derivatives as Novel, Selective, and Cellularly Active Allosteric SHP1 Activators.

Synthesis and Biological Evaluation of 3-Amino-4,4-Dimethyl Lithocholic Acid Derivatives as Novel, Selective, and Cellularly Active Allosteric SHP1 Activators.

Journal: Molecules (Basel, Switzerland)

Published: February 14, 2023

Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment.

Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment.

Journal: Journal of medicinal chemistry

Published: September 29, 2022

Enantioselective synthesis of chiral 3-alkyl-3-nitro-4-chromanones via chiral thiourea-catalysed intramolecular Michael-type cyclization.

Enantioselective synthesis of chiral 3-alkyl-3-nitro-4-chromanones via chiral thiourea-catalysed intramolecular Michael-type cyclization.

Journal: Organic & biomolecular chemistry

Published: August 13, 2021

Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish

Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish

Journal: Fa yi xue za zhi

Published: April 07, 2021

Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells.

Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells.

Journal: RSC medicinal chemistry

Published: February 26, 2021

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis.

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: February 09, 2021

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia.

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia.

Journal: Molecules (Basel, Switzerland)

Published: January 13, 2021

From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.

From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.

Journal: Journal of medicinal chemistry

Published: December 31, 2020

Showing 1-12 of 42

Last Updated: 09/26/2026